相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emerging Principles for the Therapeutic Exploitation of Glycosylation
Martin Dalziel et al.
SCIENCE (2014)
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Biosimilars in rheumatology: the wind of change
Christian K. Schneider
ANNALS OF THE RHEUMATIC DISEASES (2013)
Measures of biosimilarity in monoclonal antibodies in oncology: the case of bevacizumab
Hans C. Ebbers et al.
DRUG DISCOVERY TODAY (2013)
Clinical, Functional, and Radiographic Benefits of Longterm Adalimumab Plus Methotrexate: Final 10-year Data in Longstanding Rheumatoid Arthritis
Edward C. Keystone et al.
JOURNAL OF RHEUMATOLOGY (2013)
Scientific considerations in the review and approval of generic enoxaparin in the United States
Sau Lee et al.
NATURE BIOTECHNOLOGY (2013)
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
Kenneth Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Galactosylation variations in marketed therapeutic antibodies
T. Shantha Raju et al.
MABS (2012)
Increased serum clearance of oligomannose species present on a human IgG1 molecule
Leslie Alessandri et al.
MABS (2012)
The role of sialic acid as a modulator of the anti-inflammatory activity of IgG
Sybille Boehm et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
Andrew M. Goetze et al.
GLYCOBIOLOGY (2011)
Acceptable changes in quality attributes of glycosylated biopharmaceuticals
Martin Schiestl et al.
NATURE BIOTECHNOLOGY (2011)
Advances in the assessment and control of the effector functions of therapeutic antibodies
Xu-Rong Jiang et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Developing the Nation's Biosimilars Program
Steven Kozlowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs
Robert M. Anthony et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Charge variants in IgG1 Isolation, characterization, in vitro binding properties and pharmacokinetics in rats
Leslie A. Khawli et al.
MABS (2010)
Impact of Glycosylation on Effector Functions of Therapeutic IgG
Riad Abes et al.
PHARMACEUTICALS (2010)
Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides
Lawrence W. Dick et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function
Bernhard Antes et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Antibody therapeutics: isotype and glycoform selection
Roy Jefferis
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Characterizing biological products and assessing comparability following manufacturing changes
AJ Chirino et al.
NATURE BIOTECHNOLOGY (2004)
分享论文
